Octagon Clinical Data Standards Expert to Present at 2012 DIA EuroMeeting

- Poster Presentation Addresses Importance of the Global Adoption of CDISC Data Standards and Standards Governance -

WAYNE, Pa.--(BUSINESS WIRE)-- Octagon Research Solutions, Inc., the leader in transforming clinical R&D through an integrated suite of regulatory, clinical, process and technology solutions, announced today that Hanming Tu, Octagon’s Director, Clinical IT, will present a poster titled “The Importance of Adopting Clinical Data Interchange Standards Consortium (CDISC) Standards” at the 24th Annual DIA EuroMeeting at the Bella Center in Copenhagen, Denmark on 26-28 March 2012. The presentation underscores Octagon’s position as the global leader in clinical data strategies and standardization for the pharmaceutical industry.

Mr. Tu’s poster will provide attendees with details around the benefits and challenges of adopting clinical data standards and the strategic, business and technical considerations for successful adoption. His poster presentation will also address the benefits of adopting a standard repository system to store and track standards and manage standard’s governance processes.

“Hanming’s poster presentation creates an exceptional opportunity for global professionals to talk with an industry expert about how standards impact interoperability and integration while also driving process efficiency and data quality,” said James C. Walker, Octagon’s chairman and CEO. “Octagon’s approach is unique because it integrates the acquisition, use and archiving of clinical data throughout the product development and regulatory submission process. This improvement of processes establishes enhanced data analysis capabilities, time-to-market gains and cost efficiencies, ultimately benefitting the life science innovation environment and global patient population.”

Octagon is working with CDISC, ScenPro and the FDA to support the FDA’s large-scale complex project of converting legacy study data to an electronic standard format(s). In addition, through its CDISC-enabled solutions and services, Octagon has secured hundreds of new projects this year. The increased demand has resulted in expansion and nearly 100 new hires to date this year across Octagon’s offices including the opening of offices in Wokingham, United Kingdom, Wayne, PA, USA, and in Bangalore, India.

Walker noted, “With FDA embracing new clinical data standards, companies must also understand and embrace these standards or potentially risk longer product development and regulatory review times. Octagon understands this dynamic and has developed innovative software products and services to help the pharmaceutical industry manage this process better.”

Octagon is an active contributor to a number of industry groups including CDISC and DIA and frequently participates in various industry events.

For further information about Octagon Research Solutions, Inc., please visit the website at www.octagonresearch.com.

About Octagon Research Solutions, Inc.

Octagon is the industry leader in transforming clinical R&D through an integrated suite of regulatory, clinical, business consulting and technology solutions. With a foundation in data standards and advanced technology, Octagon’s eCTD and CDISC-enabled solutions provide all of the resources required to optimize drug development from data collection to submission. Octagon’s unique combination of deep domain knowledge, cross-functional electronic submission expertise and holistic process approach utilizing integrated solutions, set us apart as we serve more than 350 clients on three continents. Our global headquarters are in Wayne, Pennsylvania with additional US offices in Mountain View, California. Octagon also has European offices based in Wokingham, UK, and Asia-Pacific offices in Bangalore, India.

For more information, visit www.octagonresearch.com.


Octagon Research Solutions, Inc.
Ellen Semple
Senior Director, Global Marketing
Office: 610-535-6500 x. 5507
Mobile: 484-431-7546
[email protected]

KEYWORDS:   United States  Europe  North America  Denmark  Pennsylvania

INDUSTRY KEYWORDS:   Technology  Data Management  Software  Practice Management  Health  Clinical Trials  Pharmaceutical  Research  Science



Suggested Articles

While the rush to telehealth adoption may have slowed a bit from its highs early on in the pandemic, the data show consumer interest in virtual care.

Allscripts reported third-quarter 2020 revenue was $402 million, down 9% from revenue of $444 million in the third quarter of 2019. 

Telehealth giant Teladoc completed its massive $18.5 billion acquisition of Livongo, the company announced Friday.